There is still a wide gap from genomic research to real, efficient, and qualitative support for therapeutic decision making. Expert Review of Molecular Diagnostics interviews Christophe Roos, Euformatics CSO, to get his perspective on the NGS field and to learn more about Euformatics’s role in bridging the gap between translational research and the clinic. Read here.

Back to news listing